The New York Stem Cell Foundation’s (NYSCF) 18th Annual Conference convenes global leaders in stem cell research to present their latest progress towards treatments and cures...
People over the age of 75 have nearly a 30% risk of developing age-related macular degeneration (AMD), which now affects 11 million in the United States....
As NYSCF enters 2023, we’re taking a moment to look back at the defining moments of 2022. Whether it was gathering in person again for our...
Even if you don’t know Derrick Rossi, PhD, you almost certainly know Moderna: the company behind mRNA vaccine technology he co-founded that is protecting millions from...
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
“I believe in the power of stem cell science to change the lives of patients and their families,” remarked NYSCF Interim CEO Derrick Rossi, PhD, as...
“My colleagues and I are delighted to bring the NYSCF lab to you here at SNF Nostos Health today, and to show you in real time...
Alzheimer’s, Parkinson’s, multiple sclerosis, cancer: they’re all diseases that are, to this day, largely a mystery, and treatment options are scarce. But thanks to stem cells,...
2021 has been a banner year for science. With your support, we opened a new laboratory for creating clinical-grade cells to treat blindness, created stem cell...
When COVID-19 hit, Jenna Hall’s plans were completely upended. Set to embark on a PhD at the University of Melbourne in Australia, border closures meant an...
On October 5th, celebrities, scientists, and supporters ‘showed up for science’ at the The 2021 New York Stem Cell Foundation Gala. Hosted by CNN’s Chief Medical...
Age-related macular degeneration (AMD) is a leading cause of vision loss, and those over the age of 75 have a nearly 30% risk of being affected....
For patients with age-related macular degeneration (AMD), a cell therapy in development at the NYSCF Research Institute could provide what sounds like a miracle: the restoration...
The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD)....
At the root of every major disease of our time is the simple question: what is going wrong with our cells? Once scientists know exactly how...
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
The Context: Age-related macular degeneration (AMD) results from the death of retinal pigmented epithelial cells (RPEs) in the eye. Bruch’s membrane is a structure that sits...
The Context: Age-related macular degeneration (AMD) is a disease which affects 8 million Americans and can lead to severe vision loss due to death of retinal...
Last week, thousands of researchers and thought leaders gathered at the annual Phacilitate Leaders World and World Stem Cell Summit in Miami to discuss recent advancements...
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
Thanks to a groundbreaking new stem cell treatment, patients with age-related macular degeneration (AMD) are getting their sight back. This treatment was pioneered by the inaugural...
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...
NYSCF does not treat patients with stem cell therapies. Please visit www.clinicaltrials.gov for a complete listing of clinical trials being conducted worldwide, or consult your physician. Stem cell research...
In 2011 NYSCF awarded Dr. Pete Coffey the inaugural NYSCF–Robertson Stem Cell Prize for his pioneering work bringing stem cell therapies to patients with macular degeneration....
